meddevicedb.com FDA Device Reference

IBGSTAR BLOOD GLUCOSE MONITORING SYSTEM, IBGSTAR DIABETES MANAGER APPLICATION

K130535 Class II Special
Decision Date
2013-04-17
Sponsor / Applicant
Agamatrix, Inc.

Technical Specification

510(k) Submission ID K130535
Product Code NBW
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1345
Decision Date 2013-04-17
Clearance Pathway Special

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

IBGSTAR BLOOD GLUCOSE MONITORING SYSTEM, IBGSTAR DIABETES MANAGER APPLICATION received FDA 510(k) clearance under submission number K130535, sponsored by Agamatrix, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2013-04-17.

Classification & Regulation

This clearance is catalogued under FDA product code NBW and 21 CFR 862.1345, within the Clinical Chemistry review panel as a Class II device.